U.S., Aug. 28 -- ClinicalTrials.gov registry received information related to the study (NCT07144709) titled 'A 6-months Observational Study to Evaluate the Quality of Life of Patients Treated With Phytotherapy or Alpha-blockers for Benign Prostatic Hyperplasia' on July 23.
Brief Summary: This is a prospective, multicentre, non-interventional study, conducted in France and Spain, in primary care practices and designed to assess the QoL of patients under phytotherapy or alpha-blockers for LUTS/BPH. The study will not provide or recommend any treatment or procedure.
Study Start Date: June 22, 2022
Study Type: OBSERVATIONAL
Condition:
Benign Prostatic Hyperplasia
Intervention:
DRUG: Phytotherapy
Phytotherapy or alphablockers
Recruitmen...